Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jun 25, 2023
TickeronGET DAILY SIGNALS
ALGN(+6.32%) vs PAYC(+6.58%): A Comprehensive Comparison for Swing Traders

ALGN(+6.32%) vs PAYC(+6.58%): A Comprehensive Comparison for Swing Traders

Comparing ALGN and PAYC: A Deep Dive into Volatility, Price Growth, and Earnings Reports
Compare: Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) 6.32% for ALGN vs Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) 6.58% for PAYC

A Brief Overview of Swing Trading Strategies

To start, let's briefly touch on the Swing Trading strategies referenced for ALGN and PAYC. The Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) strategy delivered a strong performance for ALGN, while the Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) approach gave a strong performance for PAYC. Though these strategies have unique characteristics, both apply technical and fundamental analysis (TA&FA) to navigate market volatility and trends.

The Exits from Low Volatility to Explosive Movements strategy typically involves trading stocks that exhibit periods of low volatility followed by large price movements, whereas Trading in Markets Trending Up strategy generally capitalizes on securities in an upward market trend.

Weekly Price Growth: ALGN vs. PAYC

For the week, ALGN, which operates in the Medical Specialties industry, enjoyed a price increase of 2.56%. In contrast, PAYC, part of the Packaged Software industry, experienced a price drop of 2.34%.

When comparing these numbers to their respective industries, ALGN performed much stronger than its peers with an average weekly price drop of 0.89% in the Medical Specialties sector. PAYC, on the other hand, outperformed its industry, where the average weekly price drop was 1.07%.

Monthly and Quarterly Price Growth: An Industry Perspective

Taking a wider lens, the average monthly and quarterly price growth in the Medical Specialties industry (home to ALGN) was -0.37% and +7.41%, respectively. For the Packaged Software sector (home to PAYC), these figures were +3.70% and a robust +23.99%. The Packaged Software industry, hence, appears to have experienced higher growth over the more extended periods, underlining the importance of considering industry performance when comparing individual stocks.

Upcoming Earnings Reports

As for future expectations, both companies are due to report earnings soon. ALGN is set to announce its earnings on July 26, 2023, while PAYC is expected to report on August 1, 2023. These reports could potentially influence stock prices and should be closely monitored by investors.

In conclusion, while both ALGN and PAYC offer attractive opportunities for swing trading, they do so in distinct market contexts. Traders and investors should bear in mind these differences when devising their strategies and keep a keen eye on the upcoming earnings reports. The ongoing performance of these two companies reaffirms the importance of not only examining individual stocks but also the industries within which they operate.

Related Ticker: ALGN

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


ALGN in upward trend: price rose above 50-day moving average on November 02, 2026

ALGN moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ALGN as a result. In 58 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 31 of 42 cases over the following month. The odds of a continued upward trend are 74%.

The 10-day moving average for ALGN crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.

Following a +1.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 190 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 63 cases where ALGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 68%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

ALGN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALGN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.587) is normal, around the industry mean (4.877). P/E Ratio (26.712) is within average values for comparable stocks, (37.682). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 9.39B. The market cap for tickers in the group ranges from 126 to 154.34B. ISRG holds the highest valuation in this group at 154.34B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 11%. BLCO experienced the highest price growth at 14%, while OSUR experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 46%. For the same stocks of the Industry, the average monthly volume growth was 22% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 55
Price Growth Rating: 53
SMR Rating: 81
Profit Risk Rating: 94
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
ALGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of the invisalign system for treating malocclusion

Industry PharmaceuticalsOther

Industry
Medical Specialties
Address
410 North Scottsdale Road
Phone
+1 602 742-2000
Employees
20290
Web
https://www.aligntech.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
WDC stock surged +55% over the past 30 days, driven by robust AI-driven demand for data storage solutions. Over the past quarter, shares rose +40%, reflecting strong quarterly earnings and sustained sector momentum.
CMI stock surged +26% over the past 30 days amid analyst price target upgrades and momentum toward new 52-week highs. Over the past quarter, shares climbed +10%, rebounding from an initial post-earnings dip on positive 2026 revenue guidance and dividend hike.